108915 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Sub-classes:COMPOSITIONS AND METHODS FOR INCREASING PHYTOPHTHORA CROWN ROT RESISTANCE
#2COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING T CELL EXHAUSTION
#3GENE THERAPY FOR OCULAR DISEASE
#4Bacillus Strains for Promoting Plant Health
#5METHODS FOR GENERATING CIRCULAR NUCLEIC ACID MOLECULES
#6METHODS AND COMPOSITIONS FOR ENHANCING ROOT SYSTEM DEVELOPMENT
#7POLYNUCLEOTIDE, PROTEIN, BIOLOGICAL MATERIAL, AND USE THEREOF IN IMPROVING QUALITY OF PLANT FRUIT
#8PLANTS GENETICALLY ENGINEERED FOR INCREASED WATER USE EFFICIENCY AND CARBON INTAKE AND METHODS FOR MAKING AND USING THEM
#9Compositions and Methods for Assessing Kinase Activity
#10In Vivo Genetic Engineering of Antigen Responsive Cells
#11Fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein
#12TRANSGENIC ANIMALS EXPRESSING CHIMERIC C-KIT PROTEIN
#13USE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3) AS PROTEASE, AND GSK3-BASED PROTEOLYSIS-TARGETING CHIMERA (PROTAC) AND PREPARATION METHOD AND USE THEREOF
#14COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#15GENETICALLY ENGINEERED MICE MODELS FOR MULTIPLE MYELOMA
#16TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#17SALT TOLERANT PLANTS
#18LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR A CEBP-DELTA INHIBITOR AS THERAPEUTICS
#19SWITCH RECEPTORS AND MODIFIED IMMUNE CELLS
#20DELIVERY OF MULTI-CYTOKINE SIGNALS BY OVEREXPRESSION OF WILD-TYPE OR MUTANT SIGNAL TRANSDUCTION MOLECULES
#21SELF-ACTIVATING FÖRSTER RESONANCE ENERGY TRANSFER (saFRET) BIOSENSORS AND METHODS FOR MAKING AND USING THEM
#22ENGINEERING CHEMICALLY INDUCIBLE SPLIT PROTEIN ACTUATORS (CISPA)
#23SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT
#24Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections
#25MULTIPARTITE RECEPTOR AND SIGNALING COMPLEXES
#26EXPRESSION OF NOVEL CELL TAGS
#27Enzyme Phosphorylating 2' Hydroxyl Group of RNA
#28BIO-BASED PRODUCTION OF SUCCINIC ACID USING VIBRIO NATRIEGENS
#29LENTIVIRAL VECTOR
#30HERBICIDE-RESISTANT POLYPEPTIDE AND APPLICATION THEREOF
#31BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES
#32FUSION PROTEINS AND METHODS THEREOF
#33Mutant Taq Polymerase for Fast Speed Amplification
#34METHOD TO PRODUCE PHOSPHORYLATED MILK PROTEINS IN MICROBES
#35ANTIGEN-SPECIFIC THERAPY FOR AUTOIMMUNE DISEASES
#36METHODS OF TREATING CHOLANGIOCARCINOMA
#37EPITOPE ENGINEERING OF CELL-SURFACE RECEPTORS
#38METHOD FOR PREPARING LIPOSOMES
#39BCR-ABL VARIANTS
#40COMPOSITIONS AND METHODS FOR SOYBEAN PLANT TRANSFORMATION
#41Kinase Activity In Tumors
#42COVALENT MODIFIERS OF AKT1 AND USES THEREOF
#43HIGH-THROUGHPUT ENGINEERING OF MOLECULAR GLUES
#44ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF
#45GENETICALLY ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME
#46RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#47SGK1 INHIBITORY COMPOSITIONS AND METHODS
#48ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINES AND METHODS OF USE THEREOF
#49DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
#50C-RAF Mutants that Confer Resistance to RAF Inhibitors
#51METHODS AND SYSTEMS FOR HIGH-THROUGHPUT BIOCHEMICAL SCREENS
#52MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY
#53COMPOSITIONS, METHODS AND SYSTEMS FOR PHOSPHORYLATION OF PROTEINS IN PLANTS
#54Crystal Structures of ALK and LTK Receptor Tyrosine Kinases and Their Ligands
#55COMPOSITIONS AND METHODS FOR CONTROLLING CELL SIGNALING WITH CHIMERIC RECEPTORS
#56PROTEIN DEGRADATION SYSTEM, COMPONENTS, AND METHODS
#57SYSTEMS AND METHODS FOR DETECTION AND QUANTIFICATION OF DOUBLE-STRANDED RNA
#58METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA
#59Method for Improving Acetate Tolerance and Lipid Accumulation of Oleaginous Microorganism Using Acetyl-CoA Synthetase (ACS)
#60POLYPEPTIDE BASED ON RECEPTOR-INTERACTING PROTEIN KINASE-3 METHYLATION MODIFICATION AND APPLICATION THEREOF IN CELL NECROPTOSIS-RELATED DISEASES
#61COMPOSITIONS USEFUL IN TREATMENT OF CDKL5 DEFICIENCY DISORDER (CDD)
#62MICROORGANISMS AND METHODS FOR PRODUCING REUTERIN
#63PROTEIN-BASED CONJUGATION CARRIERS
#64VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME
#65SYMRK PHOSPHORYLATION FOR ROOT NODULE ORGANOGENESIS
#66BIOSENSORS FOR DETECTING AND/OR NEUTRALIZING BIOAVAILABLE URANIUM AND RELATED U-SENSITIVE GENETIC MOLECULAR COMPONENTS, GENE CASSETTES, VECTORS, GENETIC CIRCUITS, COMPOSITIONS, METHODS AND SYSTEMS
#67MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS
#68DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#69PYK2-DERIVED PEPTIDES FOR INHIBITING INVADOPODIA-MEDIATED CANCER METASTASIS
#70CHIMERIC ENGULFMENT RECEPTOR MOLECULES
#71METHOD FOR PROMOTING GROWTH OF PLANTS
#72ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS (CARS), CELLS EXPRESSING THE CARS AND RELATED METHODS
#73IMMUNE CELLS ENGINEERED TO PROMOTE THANOTRANSMISSION AND USES THEREOF
#74Ligand Binding Molecules and Uses Thereof
#75IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#76C2 Domain Therapeutics and Uses Thereof
#77FUSION PROTEINS AND METHODS THEREOF
#78CYANOBACTERIAL HOSTS AND METHODS FOR PRODUCING CHEMICALS
#79MERTK PEPTIDES AND USES THEREOF
#80NUCLEIC ACID MOLECULES
#81FUSION PROTEINS AND METHODS THEREOF
#82COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS USING A CD14 INHIBITOR
#83NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING
#84FUSION PROTEIN TARGETING PD-L1 AND NEUTRALIZING GAS6 AND USES THEREOF
#85GENE THERAPY FOR NEUROPROTECTION
#86NOVEL EXOSOME-BASED ANTICANCER AGENT
#87Process for the Production of Fucosylated Oligosaccharides
#88Malignant Mesothelioma Susceptibility As A Result Of Germline Leucine-Rich Repeat Kinase 2 (LRRK2) Alterations
#89MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST
#90COMPOSITIONS AND METHODS FOR TREATING RIGHT VENTRICLE DYSFUNCTION
#91GENETIC TOOLS USEFUL FOR IMPROVING A PLANT'S STRESS TOLERANCE
#92NUCLEIC ACID MOLECULES ENCODING TRIF AND ADDITIONAL POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#93LACTIC ACID BACTERIAL STRAINS WITH IMPROVED TEXTURIZING PROPERTIES
#94TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF
#95Improved T cell receptor-costimulatory molecule chimera
#96NOVEL CELL LINES, METHODS OF PRODUCING NATURAL KILLER CELLS AND USES THEREOF
#97CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING MOLECULES FOR CONTROLLED AND SPECIFIC CAR T CELL ACTIVITY
#98NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING
#99Mutant Taq polymerase providing faster amplification
#100STEM-CELL BASED BIOMARKER DISCOVERY
#101Cancer Stem Cell Targeted Cancer Vaccines
#102C-RAF mutants that confer resistance to RAF inhibitors
#103Compositions and Methods Related to Nucleic Acid Synthesis
#104HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY
#105INDUCIBLE SIGNALLING PROTEIN
#106ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS
#107Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
#108Microbial Heavy Lanthanide Acquisition and Storage with Enhanced PQQ Production
#109DOPAMINERGIC NEURONS COMPRISING MUTATIONS AND METHODS OF USE THEREOF
#110PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#111LENTIVIRAL VECTORS FOR THERAPEUTIC EXPRESSION OF BTK IN HEMATOPOIETIC CELLS
#112A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION
#113COMPOSITIONS, SYSTEMS AND METHODS FOR CRISPR-BASED ENZYME OPTIMIZATION
#114INCREASING PLANT OIL CONTENT BY IMPROVING ACTIVITY OF ACETYL COA CARBOXYLASE
#115RECEPTOR/HISTIDINE KINASE FUSION CONSTRUCTS AND USES THEREOF
#116Compositions and methods involving engineered P27
#117COMPOSITIONS AND METHODS FOR REGULATING T CELLS
#118Olivetolic Acid Cyclases for Cannabinoid Biosynthesis
#119Methods for Treating and Monitoring the Status of Cancer
#120Methods of treating cholangiocarcinoma
#121GENETICALLY MODIFIED METHYLOBACILLUS BACTERIA HAVING IMPROVING PROPERTIES
#122VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER
#123CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME
#124PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS
#125SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES
#126Protein Tyrosine Phosphatase 1B Inhibited Neutrophils, Neutrophil-Dendritic Cell Hybrids and Uses Thereof
#127FUSION PROTEINS AND METHODS THEREOF
#128RECOMBINANT NUCLEIC ACID CONSTRUCT AND USE THEREOF
#129BRK PEPTIDES AND METHODS OF USE
#130MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BUTADIENE USING ACETYL-COA
#131MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#132Targeting anabolic drugs for accelerated fracture repair
#133Genetically Modified T-Cells and PI3K/AKT Inhibitors For Cancer Treatment
#134RECOMBINANT PROTEINS FOR QUANTIFICATION OF PROTEIN LEVELS
#135Cell
#136CHEMICALLY-STABILIZED ALLOSTERIC MODULATORS OF LEUCINERICH REPEAT KINASE 2 (LRRK2)
#137METHODS OF SENSITIZING CANCER TO IMMUNOTHERAPY
#138BACTERIAL STRAINS AND METHOD FOR PRODUCING OLIGOSACCHARIDES
#139SHUTTLE PLASMID REPLICABLE IN CLOSTRIDIUM AND E. COLI AND RECOMBINANT MICROORGANISM PREPARED THEREWITH AND HAVING ENHANCED PENTOSE METABOLISM AND FERMENTATION PERFORMANCE
#140FUSION PROTEINS AND METHODS OF USE THEREOF
#141Methods for generating circular nucleic acid molecules
#142METHODS FOR TARGETED INTEGRATION
#143COMPOSITIONS AND METHODS FOR REGULATING IMMUNE SYSTEM ACTIVITY
#144Spray-Dried Tetrasaccharides
#145EXPRESSION OF MODIFIED PROTEINS IN A PEROXISOME
#146Construction of recombinant for synthesizing carminic acid and application thereof
#147CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF
#148Productivity and Bioproduct Formation in Phototropin Knock/Out Mutants in Microalgae
#149METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY INHIBITORS
#150INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF
#151POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#152COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#153METHODS OF CONTROLLING GRAIN SIZE AND WEIGHT
#154PROGNOSTIC BIOMARKER OF CANCER
#155DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#156FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY
#157LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR A CEBP-DELTA INHIBITOR AS THERAPEUTICS
#158CELLS EXPRESSING C-KIT MUTATIONS AND USES THEREOF
#159Recombinant CDKL5 Proteins, Gene Therapy and Production Methods
#160METHODS AND COMPOSITIONS FOR TREATING CANCER
#161METHOD FOR DETECTING TARGET NUCLEIC ACID, METHOD FOR DETECTING NUCLEIC ACID-BINDING MOLECULE, AND METHOD FOR EVALUATING NUCLEIC ACID-BINDING ABILITY
#162METHODS AND COMPOSITIONS FOR ENHANCING ROOT SYSTEM DEVELOPMENT
#163AN ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINE AND METHODS OF USE
#164METHOD FOR IMPROVING SALT TOLERANCE OF PLANT
#165CHIMERIC RECEPTOR SENSORS
#166TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF
#167METHODS OF USING FLT3L-Fc FUSION PROTEINS
#168ENGINEERED T CELL RECEPTORS AND USES THEREOF
#169METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE
#170TRANSGENE GENETIC TAGS AND METHODS OF USE
#171DIMERIZATION SWITCHES AND USES THEREOF
#172Cyanobacterial hosts and methods for producing chemicals
#173DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS
#174ANALYSIS OF PROTEIN KINASES IN LIVE CELLS
#175NON-HUMAN ANIMALS COMPRISING A HUMANIZED TRKB LOCUS
#176PKC-activating compounds for the treatment of neurodegenerative diseases
#177RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#178Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/Neu (ERBB2) receptor protein
#179Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections
#180HETEROARYL COMPOUNDS AND USES THEREOF
#181ENGINEERED GUANYLATE KINASE VARIANT ENZYMES
#182GLYCEROL FREE ETHANOL PRODUCTION
#183CHIMERIC INHIBITORY RECEPTOR
#184Use of Thermostable RNA Polymerases to Produce RNAs Having Reduced Immunogenicity
#185DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
#186MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY
#187Methods and compounds for the treatment or prevention of severe influenza
#188EGFR AND ROS1 KINASE IN CANCER
#189PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS
#190METHODS FOR EXTENDING THE REPLICATIVE CAPACITY OF SOMATIC CELLS DURING AN EX VIVO CULTIVATION PROCESS
#191Exosome-based anticancer agent
#192VECTORS AND EXPRESSION SYSTEMS FOR PRODUCING RECOMBINANT PROTEINS
#193BIOTIC STRESS TOLERANT PLANTS AND METHODS
#194CAMKK1 AS A NOVEL REGENERATIVE THERAPEUTIC
#195SPRAY-DRIED LACTO-N-FUCOPENTAOSE
#196METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS
#197Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
#198METHOD AND SYSTEM FOR PREDICTING COUPLING PROBABILITIES OF G-PROTEIN COUPLED RECEPTORS WITH G-PROTEINS
#199Dual leucine zipper kinase inhibitors for gene therapy
#200CONDITIONALLY ACTIVE HETERODIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#201Glycerol free ethanol production
#202ONCOLYTIC VIRUS WITH IMPROVED SAFETY AND ANTICANCER EFFECTS
#203BCR-ABL variants
#204Neoantigen peptide mimics
#205CHIMERIC PROTEINS AND CHIMERIC PROTEIN COMPLEXES DIRECTED TO FMS-LIKE TYROSINE KINASE 3 (FLT3)
#206Methods and Compositions for Treating Melanoma
#207Lentiviral vectors for therapeutic expression of BTK in haematopoietic cells
#208Pharmaceutical Composition for Treating Muscle Disease
#209COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 21 INSERTIONS
#210TRUNCATED ACTRIIB-FC FUSION PROTEINS
#211NGF Antagonists for Medical Use
#212Methods of sensitizing cancer to immunotherapy
#213NUCLEIC ACID CONSTRUCT ENCODING Trk FRAGMENT AND USE THEREOF
#214ENHANCING DROUGHT, SALINITY AND COLD TOLERANCE IN PLANTS AND TREES
#215NEW INHIBITORS OF LRRK2/PP1 INTERACTION
#216ROR1 ANTIBODY COMPOSITIONS AND RELATED METHODS
#217Recombinant proteins and their therapeutic uses
#218METHODS OF PROMOTING CELLULAR MATURATION WITH AMPK ACTIVATORS
#219Reverse Transcriptase Mutants with Increased Activity and Thermostability
#220DESIGN AND OPTIMIZATION OF TYPE IV BRAF INHIBITORS FOR THE TREATMENT OF MELANOMA
#221BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
#222ALK7:ActRIIB heteromultimers and uses thereof
#223Compositions and methods related to nucleic acid synthesis
#224Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#225TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#226ISOLATED GDF TRAP POLYPEPTIDE
#227Chimeric engulfment receptor molecules
#228BTK MUTATION AND IBRUTINIB RESISTANCE
#229IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#230Cell-based assay for determining activity in the retinoblastoma pathway
#231Expression of novel cell tags
#232Drug regulated transgene expression
#233PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#234Cell-based assay for determining activity in the retinoblastoma pathway
#235Truncated Epiderimal Growth Factor Receptor (EGFRt) for Transduced T Cell Selection
#236COMPOSITIONS AND METHODS FOR GENETICALLY-ENCODED HIGH VOLTAGE-ACTIVATED CALCIUM CHANNEL BLOCKERS USING ENGINEERED UBIQUITIN LIGASES
#237Materials and Methods for Pathologies in Muscle following Injury, Disease or Aging
#238NOVEL ALK AND NTRK1 FUSION MOLECULES AND USES THEREOF
#239MICROBIAL CELLS AND METHODS FOR PRODUCING CANNABINOIDS
#240Methods and compositions for generating doubled haploid plants and use of same in breeding
#241SURROGATE CO-RECEPTORS FOR T CELLS AND METHODS OF USE
#242METHODS OF DIAGNOSING AND TREATING CANCER IN PATIENTS HAVING OR DEVELOPING RESISTANCE TO A FIRST CANCER THERAPY
#243CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY
#244Peptides, combination of peptides as targets and for use in immunotherapy
#245C-RAF mutants that confer resistance to RAF inhibitors
#246Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#247Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#248Compositions for inhibiting KRas signaling and methods of making and using same
#249METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
#250Mutant gene associated with improvement in ethanol productivity via ethanol fermentation and method for producing ethanol using the same
#251Mutant gene associated with improvement in ethanol productivity via ethanol fermentation and method for producing ethanol using the same
#252Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
#253Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers
#254Methods for reducing LRRK2 expression
#255Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
#256Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
#257Method for preparing liposomes
#258DETECTION OF PHOSPHOKINASE SIGNATURES
#259CALCIUM DEPENDENT PROTEIN KINASE CONSTRUCTS AND USES THEREOF
#260Expression of novel cell tags
#261COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS
#262COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS
#263Kinase Activity In Tumors
#264Glycerol free ethanol production
#265REDIRECTED CELLS WITH MHC CHIMERIC RECEPTORS AND METHODS OF USE IN IMMUNOTHERAPY
#266Methods of treating cholangiocarcinoma
#267COMPOSITIONS AND METHODS FOR REDUCING SPLICEOPATHY AND TREATING RNA DOMINANCE DISORDERS
#268METHODS FOR GENERATING CIRCULAR NUCLEIC ACID MOLECULES
#269Hepatitis B virus (HBV) vaccines and uses thereof
#270TATk-CDKL5 Fusion Proteins, Compositions, Formulations, and Use Thereof
#271Engineered strain for producing allulose and derivatives thereof, method for construction therefor and use thereof
#272BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#273Protein-protein interaction assessed by detecting localized coiled coil subunits
#274TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#275CYSTEINE-REACTIVE LIGAND DISCOVERY IN PROTEOMES
#276METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS
#277In Vivo Genetic Engineering of Antigen Responsive Cells
#278Mutant gene associated with improvement in ethanol productivity via ethanol fermentation and method for producing ethanol using the same
#279STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#280CARDIAC REPAIR BY REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES
#281Spray-dried 3-fucosyllactose
#282SPRAY-DRIED TETRASACCHARIDES
#283Acetate toxicity tolerance in recombinant microbial host cells
#284Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity
#285Fusions and method for detecting same
#286DNA vectors, transposons and transposases for eukaryotic genome modification
#287Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection
#288NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF
#289Protein for regulating insect resistance in and encoding gene and use thereof
#290TREATMENT OF RETINITIS PIGMENTOSA
#291MIXED-LINEAGE KINASE DOMAIN-LIKE PROTEIN IN IMMUNOTHERAPEUTIC CANCER CONTROL
#292Cancer stem cell targeted cancer vaccines
#293Cyanobacterial hosts and methods for producing chemicals
#294Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis
#295Mutant Taq polymerase for faster amplification
#296Composition and methods for inhibiting mammalian sterile 20-like kinase 1
#297REAGENT COATED LENSES
#298Fusarium head blight disease resistance
#299COMPOSITIONS AND METHODS FOR INCREASING ETHANOL PRODUCTION BY YEAST USING GCY1 AND DAK1
#300ENGINEERED CELL DEATH-INDUCING ENZYMES AND METHODS OF USE